Clinical Trial Update: A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating nimotuzumab with gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-04-04